Literature DB >> 7406372

Delayed hemolytic transfusion reaction presenting as sickle-cell crisis.

W J Diamond, F L Brown, P Bitterman, H G Klein, R J Davey, R M Winslow.   

Abstract

Eighteen patients with sickle-cell disease underwent partial exchange transfusion. Three developed delayed hemolytic reactions, with selective disappearance of transfused cells. All reactions occurred within 6 days of transfusion, and patients presented with the clinical features of painful crises. The two most severe reactions were associated with antibodies to Jka. These patients developed fever, arthritis, and a clinical course suggesting serum sickness. In both patients, other alloantibodies had previously been seen. A fourth patient developed multiple alloantibodies, accelerated destruction of tranfused cells, but milder illness. Such reactions may be commoner than in appreciated and should be suspected when patients have recurrent or severe sickle crises after transfusion. Blood that is nonimmunogenic in antigen systems frequently associated with delayed hemolytic reactions (Rh, Kell, Duffy, and Kidd) is preferred for sickle-cell patients who lack these antigens, especially if these patients have previously demonstrated capability to form erythrocyte alloantibodies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7406372     DOI: 10.7326/0003-4819-93-2-231

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  9 in total

1.  Delayed haemolytic transfusion reactions in patients with sickle cell disease.

Authors:  D Cummins; G Webb; N Shah; S C Davies
Journal:  Postgrad Med J       Date:  1991-07       Impact factor: 2.401

Review 2.  Lessons learned from mouse models of hemolytic transfusion reactions.

Authors:  Eldad A Hod; James C Zimring; Steven L Spitalnik
Journal:  Curr Opin Hematol       Date:  2008-11       Impact factor: 3.284

Review 3.  The hazards of blood transfusion in historical perspective.

Authors:  Harvey J Alter; Harvey G Klein
Journal:  Blood       Date:  2008-10-01       Impact factor: 22.113

4.  Delayed hemolytic transfusion reaction in a thalassemic child.

Authors:  R Kashyap; V P Choudhry
Journal:  Indian J Pediatr       Date:  1994 Nov-Dec       Impact factor: 1.967

5.  CXCL1 and its receptor, CXCR2, mediate murine sickle cell vaso-occlusion during hemolytic transfusion reactions.

Authors:  Jung-Eun Jang; Eldad A Hod; Steven L Spitalnik; Paul S Frenette
Journal:  J Clin Invest       Date:  2011-03-07       Impact factor: 14.808

Review 6.  Delayed hemolytic transfusion reaction in sickle cell disease.

Authors:  Leslie P Scheunemann; Kenneth I Ataga
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378

7.  When a transfusion in an emergency service is not really urgent: hyperhaemolysis syndrome in a child with sickle cell disease.

Authors:  Sara Chinchilla Langeber; Marta Pilar Osuna Marco; María Benedit; Áurea Cervera Bravo
Journal:  BMJ Case Rep       Date:  2018-03-27

8.  Red Blood Cell Alloimmunization in Sickle Cell Disease Patients in Tanzania.

Authors:  E Meda; P M Magesa; T Marlow; C Reid; D J Roberts; J Makani
Journal:  East Afr J Public Health       Date:  2014

9.  Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal.

Authors:  Swee Lay Thein; France Pirenne; Ross M Fasano; Anoosha Habibi; Pablo Bartolucci; Satheesh Chonat; Jeanne E Hendrickson; Sean R Stowell
Journal:  Haematologica       Date:  2020-02-06       Impact factor: 11.047

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.